Feedback / Questions
ALN-PCS01 - Alnylam, Novartis
Alynlam: Corporate Overview
(Alnylam)
-
Jan 17, 2013 -
Anticipated partnership to initiate P2 trials for severe hypercholesterolemia in 2013
Anticipated licensing / partnership • Anticipated new P2 trial
•
Dyslipidemia
http://www.larvolonline.com/tlg/ccdb/AlynlamCorporateOverviewJan072013.pdf
Jan 17, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.